Lorcaserin Extended-Release Tablets and Medroxyprogesterone Acetate
Determining the interaction of Lorcaserin Extended-Release Tablets and Medroxyprogesterone Acetate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: Medroxyprogesterone, MedroxyPROGESTERone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Medroxyprogesterone injection
- Lorcaserin Extended-Release Tablets-Medroxyprogesterone Injection (400 mg/mL)
- Lorcaserin Extended-Release Tablets-Medroxyprogesterone Injection (Intramuscular)
- Lorcaserin Extended-Release Tablets-Medroxyprogesterone Injection (Subcutaneous)
- Lorcaserin Extended-Release Tablets-Medroxyprogesterone Injection ER
- Lorcaserin Extended-Release Tablets-Medroxyprogesterone Intramuscular
- Medroxyprogesterone Acetate-Lorcaserin Hydrochloride
- Medroxyprogesterone Acetate-Lorcaserin Tablets
- Medroxyprogesterone Acetate-Lorcet
- Medroxyprogesterone Acetate-Lorcet Plus
- Medroxyprogesterone Acetate-Lorcet Tablets
- Medroxyprogesterone Acetate-Lorlatinib